NCT07398976 Sex Differences in E-Cigarette Perception
| NCT ID | NCT07398976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Nicotine Dependence |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-07-30 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-07-30 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines differences between males and females in the appeal and addiction potential of menthol flavored e-cigarettes with and without nicotine.
Eligibility Criteria
Inclusion Criteria: * Able to read/write in English * Current cigarette smoking * Prior e-cigarette exposure * Biochemically verified cigarette use * Not trying to quit tobacco use Exclusion Criteria: * Significant medical concerns that would increase study risk * Use of psychoactive drugs unless prescribed and stable * Allergy to menthol or other e-liquid ingredients * Dislike of menthol * Pregnant, trying to get pregnant, breastfeeding
Contact & Investigator
Danielle R Davis, PhD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT07398976 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 44 Years, studying Nicotine Dependence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07398976 currently recruiting?
Yes, NCT07398976 is actively recruiting participants. Contact the research team at danielle.davis@yale.edu for enrollment information.
Where is the NCT07398976 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT07398976 clinical trial?
NCT07398976 is sponsored by Yale University. The principal investigator is Danielle R Davis, PhD at Yale University. The trial plans to enroll 60 participants.